RxDoctor Payments DataLook up a doctor →

Biovance: payments to doctors

Payments that named Biovance as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$189K
Providers
322
Transactions
590
Average per transaction
$321

The per-transaction average — $321 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 322 providers the average total is $588, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Celularity, Inc.$157,97583.4%
Celularity Inc.$31,37016.6%
← All drugs & devices